Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Azilsartan impurity 10 is a chemical impurity related to the antihypertensive agent Azilsartan. This compound serves as a reference standard for analytical methods used in the characterization and quantification of drug impurities. Its use is essential in the development and quality control of pharmaceutical formulations to ensure compliance with regulatory standards. -
Drug Impurity
Escitalopram impurity 3 is a known impurity of the selective serotonin reuptake inhibitor Escitalopram, primarily involved in the pharmacological modulation of serotonin levels in the brain. Its characterization is essential for ensuring the quality and safety of pharmaceutical formulations containing Escitalopram. This reagent serves as a reference standard in studies focusing on impurity profiling and the evaluation of product stability in drug development and quality control processes. -
Drug Impurity
Sildenafil impurity 16 is a chemical impurity related to the phosphodiesterase type 5 (PDE5) inhibitor Sildenafil. As an impurity, it may be of interest in analytical chemistry for purity assessment and characterization of Sildenafil formulations. This compound is crucial for quality control and compliance in pharmaceutical development, particularly in the synthesis and evaluation of PDE5 inhibitors. -
Drug Impurity
Acyclovir impurity 5 is a characterized impurity of Acyclovir, an antiviral medication targeting viral DNA polymerase. This compound is essential for the evaluation of drug purity and safety, making it useful in the analysis of formulation quality and compliance with regulatory standards in pharmaceutical development. It serves as a crucial reference material for method validation and quality control in laboratories engaged in antiviral research and drug formulation studies. -
Betahistine Impurity
N,N-Dimethyl-2-pyridineethylamine is an identified impurity of Betahistine, a medication primarily used for the treatment of vestibular disorders. This compound serves as a useful reference standard in the analysis of Betahistine's purity and quality in pharmaceutical research. Its presence may influence the pharmacokinetics and safety profile of Betahistine, making it significant for analytical and quality control laboratories engaged in drug development and testing. -
Drug Impurity
Dexmedetomidine impurity 5 is identified as N-Ethylmedetomidine, a structural impurity of Dexmedetomidine. This compound plays a critical role in quality control and analytical studies to ensure the purity and safety of dexmedetomidine formulations. Researchers may utilize this impurity to investigate its effects in pharmacokinetic and toxicological assessments, thereby contributing to a better understanding of drug metabolism and efficacy. -
Drug Impurity
Trimetazidine impurity 5 is a drug impurity associated with trimetazidine, a medication primarily used for the treatment of angina pectoris. This compound serves as an important reference standard for the analysis and characterization of trimetazidine formulations in pharmaceutical research. It is essential for ensuring the quality and purity of drug substances, facilitating the development and validation of analytical methods in drug testing and quality control. -
Drug Impurity
Trazodone impurity 10, also known as Trazodone N-Oxide, is a known impurity found in Trazodone synthesis. Its presence can influence the pharmacological profile and safety evaluation of Trazodone formulations. This compound serves as a valuable reference for analytical method development, quality control, and stability studies within pharmaceutical research focused on Trazodone-related compounds. -
Drug Impurity
Beclometasone dipropionate impurity 3 is a known impurity associated with Beclometasone dipropionate, a corticosteroid medication. This compound can be utilized in the assessment of drug purity and stability, contributing to the quality control of pharmaceutical formulations. Researchers may employ this impurity in analytical testing protocols to ensure compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Roxithromycin impurity 4, also known as Roxithromycin impurity D, is a chemical byproduct associated with the antibiotic Roxithromycin. This impurity can be utilized in research focused on the synthesis and characterization of drug formulations, particularly in assessing the quality and stability of Roxithromycin. Understanding impurities like Roxithromycin impurity 4 is crucial for regulatory compliance and ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Atorvastatin impurity 2 calcium is a known impurity of the cholesterol-lowering agent Atorvastatin calcium. This compound is utilized primarily in the quality control and analytical assessment of Atorvastatin formulations to ensure purity and compliance with pharmacopoeial standards. The characterization of this impurity is essential for researchers engaged in pharmaceutical development and regulatory submissions. -
Drug Intermediate
DOTA-PEG4-OSu is a bifunctional conjugate that combines a chelating agent with a PEG-based linker. It serves as a crucial intermediate for synthesizing radionuclide reagents, specifically 68Ga-DOTA-PEG4-(GGG-cKiE)2. This compound is instrumental in radiopharmaceutical applications, particularly in the development of targeted imaging agents for diagnostic purposes. -
Drug Impurity
Linagliptin impurity 1, also known as Bromo butene linagliptin impurity VII, is a specific drug impurity associated with Linagliptin. This compound may serve as a reference standard in analytical studies focused on the purity assessment and quality control of Linagliptin formulations. Researchers can utilize this impurity to evaluate the presence and concentration of impurities during the development and manufacturing processes of related pharmaceutical products. -
Drug Impurity
Atenolol impurity 6 is a byproduct of Atenolol synthesis. As a drug impurity, it serves as an important reference standard for quality control and analytical testing in pharmaceutical development. This compound is utilized to assess the purity of Atenolol and to study its potential effects during formulation and stability testing. -
Drug Impurity
Citalopram impurity 4 oxalate, also known as 3-Oxocitalopram oxalate, is a recognized impurity associated with the synthetic pathway of Citalopram oxalate. This compound serves as a crucial standard in pharmaceutical quality control, enabling the identification and quantification of impurities in Citalopram formulations. Its presence is relevant in research focused on drug metabolism and the assessment of drug purity and safety in pharmacological studies. -
Aceclofenac Impurity
Aceclofenac methyl ester is a key impurity of Aceclofenac, an orally active nonsteroidal anti-inflammatory drug (NSAID) recognized for its analgesic and anti-inflammatory effects. This compound is significant for research applications involving the characterization and validation of Aceclofenac, allowing for a comprehensive analysis of its pharmacological profile and potential impact in various inflammatory conditions. -
Drug Intermediate
2-(3-Pyridyl)-4-methyl-thiazole-5-carboxylic acid is a synthetic intermediate utilized in pharmaceutical synthesis. This compound serves as a building block for the development of various drug candidates, contributing to the formation of thiazole-based pharmacophores. It is applicable in medicinal chemistry for creating novel therapeutics with potential biological activity. -
Drug Impurity
Clopidogrel impurity 10 is an impurity associated with the antiplatelet drug Clopidogrel, which primarily targets the P2Y12 receptor on platelets. This impurity is critical for evaluating the purity and quality of Clopidogrel formulations in pharmaceutical research. It serves as a reference standard in drug development and quality control processes, ensuring the reliability of therapeutic applications. -
Drug Impurity
Beclometasone dipropionate impurity 9 is a known impurity associated with the corticosteroid Beclometasone dipropionate. It serves as a critical reference standard for quality control and analysis in pharmaceutical development, ensuring the purity and safety of corticosteroid formulations. Its characterization is essential for regulatory compliance and in assessing the stability and efficacy of related drug products. -
Drug Intermediate Control
2-Methyl-4-phenyl thiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the production of various bioactive molecules, facilitating the development of potential therapeutics. Its application spans across medicinal chemistry, where it aids in the design and optimization of new drug candidates. -
Drug Impurity
Atorvastatin impurity 9 is a chemical impurity associated with the statin drug Atorvastatin. It is primarily studied for its role in drug quality control and formulation integrity. This impurity is relevant for researchers investigating the safety and efficacy profiles of Atorvastatin, contributing to the understanding of its pharmacological properties and potential impacts on patient treatment outcomes. -
Drug Impurity
Chlorthalidone impurity 2 is an identified impurity associated with the antihypertensive agent Chlorthalidone. This compound is primarily utilized in analytical chemistry to assess the purity and quality of Chlorthalidone in pharmaceutical formulations. It serves as a crucial reference standard for researchers investigating the metabolite profile and potential side effects of Chlorthalidone-based therapies. -
Drug Intermediate
(1S,3S)-3-Aminomethyl-cyclopentanol is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural framework provides a valuable scaffold for the development of various bioactive compounds, making it essential in medicinal chemistry. This reagent is applicable in research focused on the synthesis of novel therapeutics and drug discovery. -
Drug Impurity
Tamsulosin impurity 3 is a recognized impurity associated with Tamsulosin, a selective alpha-1 adrenergic antagonist. This compound serves as an important reference standard in the pharmaceutical industry for quality control and stability testing of Tamsulosin formulations. Its characterization aids in ensuring the purity and safety of therapeutic preparations utilizing Tamsulosin. -
Drug Impurity
Fenirofibrate impurity 2 is a minor impurity associated with the lipid-modulating drug Fenirofibrate. This compound is relevant for drug quality control and stability testing in pharmaceutical research. Its identification and quantification play a crucial role in ensuring the purity and safety of Fenirofibrate formulations, aiding in the development of effective therapeutic strategies for dyslipidemia. -
Drug Impurity
Trazodone impurity 1, also known as Trazodone 1,4-Di-N-oxide, is a known impurity associated with the pharmaceutical compound Trazodone. This reagent is utilized primarily in the assessment of drug purity and stability during analytical testing. Its presence and quantification are critical for ensuring the quality of Trazodone formulations in pharmaceutical research and development. -
Drug Impurity
Lidocaine impurity 20 is a known impurity associated with the local anesthetic agent Lidocaine. This compound serves as a critical reference standard for quality control during the synthesis and analysis of Lidocaine formulations. Its identification and characterization are essential for ensuring the purity and efficacy of Lidocaine-containing products in pharmaceutical research and development. -
Drug Impurity
Trazodone impurity 2, also known as Dechloro trazodone, is a known impurity associated with the pharmaceutical compound Trazodone. This compound may be utilized in the assessment of drug purity and stability during formulation development and quality control processes. Its analysis can provide valuable insights into the chemical profile of Trazodone formulations, aiding in the understanding of potential impacts on efficacy and safety. -
Drug Impurity
Ethinylestradiol impurity 2, also known as 16-Oxo ethynyl estradiol, serves as a notable impurity in the synthesis of Ethinylestradiol. Its characterization is essential for quality control and regulatory compliance in pharmaceutical development. This compound can be utilized in various analytical applications, including stability studies and impurity profiling, providing critical insights into the purity and safety of hormone-related therapeutic formulations. -
Drug Impurity
Clobazam impurity 4 is a chemical impurity associated with the pharmaceutical agent Clobazam, a benzodiazepine used primarily for its anxiolytic properties. This impurity may arise during the synthesis of Clobazam and is relevant for analytical chemistry and quality control in drug development. Research applications include the assessment of drug purity, stability studies, and pharmacokinetic investigations. -
Drug Impurity
Trazodone impurity 4 hydrochloride is a chemical impurity associated with Trazodone hydrochloride. It serves as an important reference standard in the evaluation of drug purity and is relevant for quality control processes in pharmaceutical research. The presence of this impurity can impact the pharmacological profile and safety of formulations containing Trazodone, making it essential for analytical methods in drug development and regulatory compliance. -
Drug Impurity
Candesartan impurity 11 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This impurity is significant for quality control and analytical studies in pharmaceutical research, particularly for characterizing Candesartan formulations. Its presence can affect the safety and efficacy profiles of drug products, making it essential for thorough impurity profiling in drug development processes. -
Drug Impurity
Sitagliptin impurity 19 is a chemical impurity associated with the antidiabetic agent Sitagliptin. It is utilized primarily in pharmaceutical development and quality control to assess the purity and stability of Sitagliptin formulations. This reagent is essential for ensuring compliance with regulatory standards and for conducting detailed investigations into the drug's chemical profile. -
Drug Impurity
Rivaroxaban impurity 33 is a drug impurity associated with Rivaroxaban, an anticoagulant that inhibits Factor Xa. This impurity is vital for quality control and analytical studies in pharmaceutical development and can be used in characterizing the purity of Rivaroxaban formulations. Its presence is significant for researchers involved in drug safety assessments and regulatory compliance in pharmaceutical research. -
Drug Impurity
Betamethasone dipropionate impurity 2 is a known impurity of the corticosteroid, Betamethasone dipropionate, which serves as a glucocorticoid receptor agonist. This compound may be relevant for research involving the purification and characterization of drug formulations, as well as studies on the stability and efficacy of corticosteroid therapies. Understanding this impurity is essential for ensuring quality control in the production of pharmacologically active compounds. -
Drug Impurity
Dabigatran impurity 2 is a quality control reference standard identified as an impurity of Dabigatran. This compound is utilized primarily in analytical chemistry for the detection and quantification of impurities in Dabigatran formulations. It serves as a critical reagent for research focused on the pharmacokinetics and safety profiles of anticoagulant medications. -
Drug Impurity
Donepezil impurity 21 is a known impurity of the cognitive-enhancing agent Donepezil, which primarily targets acetylcholinesterase to enhance cholinergic neurotransmission. This compound is essential for the analysis of Donepezil formulations, particularly in the context of pharmaceutical quality control and regulatory compliance. Its characterization aids in understanding the stability and purity of Donepezil, supporting ongoing research in neurodegenerative disease therapies. -
Drug Impurity
Lincomycin impurity 4 is a known impurity associated with lincomycin, an antibiotic that targets the bacterial ribosome to inhibit protein synthesis. This compound serves as an important reference standard for quality control and analytical assessment in pharmaceutical development and research. It is valuable for studying the stability, efficacy, and safety profiles of lincomycin formulations. -
Drug Impurity
Oxcarbazepine impurity 3, also known as 11-Keto Oxcarbazepine, is a recognized impurity of the anticonvulsant drug Oxcarbazepine. This compound is relevant in the pharmaceutical research and quality control of antiepileptic medications. Its presence and characterization are essential for ensuring the purity and efficacy of drug formulations. -
Drug Impurity
Hydrocortisone impurity 3 (Cortexolone hemisuccinate) is a known impurity of hydrocortisone, primarily utilized in quality control and analytical research. It serves as an important reference standard for assessing the purity of hydrocortisone formulations. Research applications include stability testing and identification of degradation products in pharmaceutical development. -
Drug Impurity
Haloperidol impurity 10 is a characterized impurity of the antipsychotic drug Haloperidol. It serves as a reference standard in quality control and analytical studies, aiding in the assessment of drug purity. This compound is essential for researchers focused on drug development and regulatory compliance, allowing for the evaluation of related substances and potential effects on therapeutic efficacy. -
Drug Impurity
Cinacalcet impurity 9 is a known impurity of the calcium-sensing receptor modulator, Cinacalcet. This compound serves as a reference standard for quality control and method validation in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Cinacalcet-containing formulations, aiding in the development of robust analytical methods in drug formulation studies. -
Drug Impurity
Amlodipine impurity 6 is a specific impurity associated with Amlodipine, a calcium channel blocker. This compound is primarily utilized in analytical and quality control applications to ensure the purity of Amlodipine formulations. Its characterization is crucial for regulatory compliance and the development of safe and effective therapeutic agents. -
Drug Impurity
Ketoconazole impurity 6 is a known impurity associated with Ketoconazole, a commonly used antifungal agent. The identification and characterization of this impurity are crucial for ensuring the quality and safety of pharmaceutical formulations. This compound can serve as a reference standard in drug development and analytical studies, aiding in the assessment of Ketoconazole purity and stability in various research applications. -
Drug Impurity
Cetirizine impurity 2 is a chemical impurity associated with the antihistamine cetirizine. It is primarily utilized in pharmaceutical research to assess the quality and purity of cetirizine formulations. This compound plays a crucial role in stability testing and compliance with regulatory standards for drug substances. -
Drug Intermediate
BOC-(1R,3S)-3-aminocyclopentane carboxylic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its structural components make it valuable in the development of bioactive compounds, particularly in generating cyclic amino acids. This compound supports various research applications, including the synthesis of peptidomimetics and the exploration of drug candidates targeting specific biological pathways. -
Drug Impurity
Dacomitinib impurity 1 is a known impurity of the targeted therapy Dacomitinib, which acts as an irreversible inhibitor of the epidermal growth factor receptor (EGFR). This compound is primarily utilized in quality control and stability testing within pharmaceutical research to ensure the purity and efficacy of Dacomitinib formulations. Its presence is crucial for understanding potential impacts on drug performance and safety in therapeutic applications. -
Drug Impurity
Testosterone impurity 11 is a known impurity associated with the synthesis of testosterone. Its presence in formulations may affect the purity and efficacy of therapeutic preparations. This compound is relevant in analytical chemistry, particularly in the assessment of drug quality and safety for research applications focusing on steroid hormones and their derivatives. -
Drug Impurity
Albendazole impurity 2 is a known impurity of the anthelmintic agent albendazole, primarily investigated for its potential impact on drug quality and safety. This compound is essential for the assessment of purity in pharmaceutical formulations of albendazole and can be used in the development and validation of analytical methods. It plays a crucial role in ensuring compliance with regulatory standards and quality control in drug manufacturing processes. -
Drug Impurity
Rivaroxaban impurity 20 is a known impurity of the anticoagulant Rivaroxaban, functioning primarily as a pharmacological marker in chemical analysis. This reagent is essential for the development and quality control of pharmaceutical formulations, enabling researchers to assess the purity and safety of Rivaroxaban products. Its characterization is crucial in compliance with regulatory standards during synthesis and formulation processes.
